Trading Signals: CAPR Stock Price Prediction and Forecast (Tue. Apr. 1, 2003 - Fri. Jul. 2, 2021)(Capricor Therapeutics Inc)
| CAPR latest price $440.0000 (-3.3%) ($325.0000 - $465.0000) on Sun. Jan. 18, 2009. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 16.18% (three month average) | RSI | 47 | Latest Price | $440.0000(-3.3%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CAPR declines -2.2% a day on average for past five trading days. | Weekly Trend | CAPR advances 0.9% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support CAPR advance at 0% a week (0% probability) (0%) (0%) (0%) (0%) (0%) | Factors Impacting CAPR price | CAPR will decline at least -8.09% in a week (0% probabilities). (0%) (0%) (0%) (0%) (0%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -8.09% (StdDev 16.18%) | Hourly BBV | 0 () | Intraday Trend | -5.4% | | | |
|
Resistance Level | $457.04 | 5 Day Moving Average | $449(-2%) | 10 Day Moving Average | $456.89(-3.7%) | 20 Day Moving Average | $457.04(-3.73%) | To recent high | -68% | To recent low | 109.5% | Market Cap | $N/A | | | | Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of first-in-class biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded in August 2005 and is headquartered in Beverly Hills, CA. |